Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, and Volpara Health, a company that offers AI-powered software to help providers better understand cancer risk, announced they are joining forces to develop a comprehensive ecosystem for early cancer detection, cancer risk prediction and independent AI to improve clinical workflows.
In May, Lunit acquired Volpara...
South Korean medical imaging AI company Neurophet has received second clearance for its brain image analysis software in the United States.
It obtained another 510(k) from the US Food and Drug Administration for the latest functionality on Neurophet Aqua that analyses multiple sclerosis and white matter hyperintensities using T2-FLAIR images.
The brain MRI scan-based analysis software, which...
Lunit collabs with AstraZeneca, secures major deal in France
Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims to accelerate the time-consuming process of genomic testing as part of NSCLC identification and diagnosis by leveraging Lunit's AI. The latter's...
Aevice Health obtains $1M investment for Japan, US expansion
Singapore-based respiratory health IT maker Aevice Health has received a $1 million investment from A&D Company for its expansion in the United States and Japan.
Based on their agreement, Aevice can leverage the sales network of its investor, which manufactures precision equipment and product inspection equipment for healthcare and...
South Korean medical AI company Lunit has recently secured deals with hospitals in Europe, where the medical device market – the second largest after the North American market – is worth $155 billion.
It won the contract to supply a lung disease screening solution to TeleDiag, the largest teleradiology group in France.
Lunit was also chosen to provide a mammography analysis solution to the...
Samsung to integrate Lunit's AI in premium X-ray devices
South Korean medical AI provider Lunit has signed a three-year supply contract with Samsung Electronics.
The deal is for the integration of Lunit's two chest X-ray AI solutions – Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage – into Samsung's line of premium X-ray devices.
According to a press release, the AI-integrated X-ray devices will...
Shareholders of KOSDAQ-listed Lunit have recently participated in the company's recent capital raise, paying-in $150 million to fund its development of "next-generation" products and further expansion in the West.
Meanwhile, the AI cancer diagnostics solutions provider obtained its third 510(k) clearance from the United States Food and Drug Administration.
WHAT IT'S FOR
In a company disclosure,...
Nesa obtains US FDA 510(k) for fibroid mapping tech
Indian femtech Nesa Medtech has received the United States Food and Drug Administration 510(k) clearance for its fibroid mapping tool.
Its Fibroid Mapping Reviewer Application assists in the diagnosis and planning of interventional procedures for patients with uterine fibroids. It generates a 3D model of the uterus from ultrasound images where...
Saudi Arabia's Seha Virtual Hospital, touted as the largest virtual hospital in the world, has chosen South Korean medical AI company Lunit to deliver AI solutions to support the kingdom's national cancer and tuberculosis screening programme.
Launched in 2022, Seha Virtual Hospital is a key piece of healthcare innovation under "Saudi Vision 2030." The hospital is providing medical services to...
Medical IP gets US FDA nod for AI body composition analysis software
South Korean medical imaging company Medical IP has obtained a United States Food and Drug Administration 510(k) clearance for its AI-powered body composition analysis software.
According to the company, DeepCatch is the first FDA-approved AI software that automatically analyses body components, such as skin, bone, muscle,...
